cbdMD, Inc. (YCBD) |
|
1.0568 0.022 (2.11%)
|
09-27 15:59 |
|
Open: |
1.07 |
Pre. Close: |
1.035 |
|
High:
|
1.075 |
Low:
|
1.04 |
|
Volume:
|
24,976 |
Market Cap:
|
3(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 4:23:10 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 1.68 One year: 1.98 |
| Support: |
Support1: 1.01 Support2: 0.84 |
| Resistance: |
Resistance1: 1.43 Resistance2: 1.69 |
| Pivot: |
1.2  |
| Moving Average: |
MA(5): 1.05 MA(20): 1.18 
MA(100): 1.49 MA(250): 7.25 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 3.5 %D(3): 4.4 |
| RSI: |
RSI(14): 39.7 |
| 52-week: |
High: 20.25 Low: 1.01 |
| Average Vol(K): |
3-Month: 46 (K) 10-Days: 41 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ YCBD ] has closed above bottom band by 18.7%. Bollinger Bands are 33.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.08 - 1.08 |
1.08 - 1.09 |
|
Low:
|
1.03 - 1.03 |
1.03 - 1.04 |
|
Close:
|
1.03 - 1.04 |
1.04 - 1.05 |
|
Company Description |
|
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. |
Headline News |
Fri, 22 Sep 2023
2023-09-22 | NYSEAM:YCBD | Press Release | cbdMD Inc - Stockhouse Publishing
Fri, 22 Sep 2023
Breaking Barriers: cbdMD's Research Validates Safe CBD Upper ... - InvestorsObserver
Wed, 13 Sep 2023
Healthcare Stocks on the Move Wednesday: RCKT, AWH, VIGL, CDXS, HOTH, YCBD, FLGC, CELZ - InvestorsObserver
Tue, 05 Sep 2023
Should You Add cbdMD Inc (YCBD) Stock to Your Portfolio Tuesday? - InvestorsObserver
Fri, 25 Aug 2023
Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award - Yahoo Finance
Thu, 17 Aug 2023
ON REGULATION OF CBD PRODUCTS - cbdMD
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
